Complexed prostate-specific antigen and the "prostate-specific antigen gap"

被引：0
|
作者：
Croal, BL [1 ]
Mitchell, I
Dickie, A
Duff, PA
Cohen, NP
Ross, IS
机构：
[1] Grampian Univ Hosp Trust, Dept Clin Biochem, Aberdeen AB25 2ZD, Scotland
[2] Grampian Univ Hosp Trust, Dept Urol, Aberdeen AB25 2ZD, Scotland
来源：
CLINICAL CHEMISTRY | 1999年 / 45卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：2040 / 2040
页数：1
相关论文
共 50 条
  • [1] Effect of prostate manipulation on the serum levels of complexed prostate-specific antigen and total prostate-specific antigen
    Long, Ronan
    Giri, Subhasis
    Diver, Sean
    Duddy, Lorna
    McKeown, Declan
    Moran, Kevin
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (07) : 947 - 950
  • [2] Complexed prostate-specific antigen - Introduction
    Brawer, MK
    [J]. UROLOGY, 2002, 60 (4A) : 1 - 3
  • [3] Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: Results of the prospective multicenter European trial
    Djavan, B
    Remzi, M
    Zlotta, AR
    Ravery, V
    Hammerer, P
    Reissigl, A
    Dobronski, P
    Kaisary, A
    Marberger, M
    [J]. UROLOGY, 2002, 60 (4A) : 4 - 9
  • [4] Complexed prostate-specific antigen for the detection of prostate cancer
    Filella, X
    Truan, D
    Alcover, J
    Gutierrez, R
    Molina, R
    Coca, F
    Ballesta, AM
    [J]. ANTICANCER RESEARCH, 2004, 24 (06) : 4181 - 4185
  • [5] The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen
    Herrmann, W
    Stöckle, M
    Sand-Hill, M
    Hübner, U
    Herrmann, M
    Obeid, R
    Wullich, B
    Loch, T
    Geisel, J
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (09) : 1051 - 1057
  • [6] Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen
    Sokoll, LJ
    Bruzek, DJ
    Dua, R
    Dunn, W
    Mohr, P
    Wallerson, G
    Eisenberger, M
    Partin, AW
    Chan, DW
    [J]. UROLOGY, 2002, 60 (4A) : 24 - 30
  • [7] Western blotting analysis of antibodies to prostate-specific antigen: Specificities for prostate-specific antigen and prostate-specific antigen fragments
    Wang, TJ
    Linton, HJ
    Sokoloff, RL
    Grauer, LS
    Rittenhouse, HG
    Wolfert, RL
    [J]. TUMOR BIOLOGY, 1999, 20 : 79 - 85
  • [8] Prostate-specific antigen velocity and repeated measures of prostate-specific antigen
    Carter, HB
    Pearson, JD
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 1997, 24 (02) : 333 - &
  • [9] Complexed prostate-specific antigen, and complext prostate-specific antigen indices for early detection of prostate cancer in men with total prostate-specific antigen between 2.0 and 4.0 ng/ml
    Reissigl, A
    Remzi, M
    Wiunig, C
    Zlotta, A
    Ravery, V
    Hammerer, P
    Dobronski, P
    Kaisary, A
    Marberger, M
    Djavan, B
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 426 - 427
  • [10] Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis
    Lein, M
    Jung, K
    Elgeti, U
    Petras, T
    Stephan, C
    Brux, B
    Sinha, P
    Winkelmann, B
    Schnorr, D
    Loening, SA
    [J]. EUROPEAN UROLOGY, 2001, 39 (01) : 57 - 64
12345